Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
DXA3LI
|
||||
| Drug Name |
((S)-1-Formyl-pentyl)-carbamic acid 1-benzyl-cyclohexyl ester
|
||||
| Synonyms |
CHEMBL117144
|
||||
| Indication | Discovery agent | Investigative | [1587926] | ||
| Formula |
C20H29NO3
|
||||
| Canonical SMILES |
CCCC[C@H](NC(=O)OC1(Cc2ccccc2)CCCCC1)C=O
|
||||
| InChI |
InChI=1S/C20H29NO3/c1-2-3-12-18(16-22)21-19(23)24-20(13-8-5-9-14-20)15-17-10-6-4-7-11-17/h4,6-7,10-11,16,18H,2-3,5,8-9,12-15H2,1H3,(H,21,23)/t18-/m0/s1
|
||||
| InChIKey |
YJJMLMACEQCKEM-SFHVURJKSA-N
|
||||
| Target and Pathway | |||||
| Target(s) | Cathepsin K | Target Info | [1587926] | ||
| Cathepsin L | Target Info | [1587926] | |||
| Reactome | Collagen degradation | ||||
| Degradation of the extracellular matrix | |||||
| Activation of Matrix Metalloproteinases | |||||
| Trafficking and processing of endosomal TLR | |||||
| MHC class II antigen presentationR-HSA-1236977:Endosomal/Vacuolar pathway | |||||
| Assembly of collagen fibrils and other multimeric structures | |||||
| MHC class II antigen presentation | |||||
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.